- Home
- APLT vs AMAL Comparison
APLT vs AMAL Comparison
Compare APLT & AMAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- AMAL
- Stock Information
- Founded
- APLT 2016
- AMAL 1923
- Country
- APLT United States
- AMAL United States
- Employees
- APLT N/A
- AMAL N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- AMAL Commercial Banks
- Sector
- APLT Health Care
- AMAL Finance
- Exchange
- APLT Nasdaq
- AMAL Nasdaq
- Market Cap
- APLT 128.0M
- AMAL 1.0B
- IPO Year
- APLT 2019
- AMAL 2018
- Fundamental
- Price
- APLT $0.94
- AMAL $33.03
- Analyst Decision
- APLT Buy
- AMAL Buy
- Analyst Count
- APLT 7
- AMAL 4
- Target Price
- APLT $6.10
- AMAL $37.13
- AVG Volume (30 Days)
- APLT 8.9M
- AMAL 146.4K
- Earning Date
- APLT 11-07-2024
- AMAL 01-23-2025
- Dividend Yield
- APLT N/A
- AMAL 1.43%
- EPS Growth
- APLT N/A
- AMAL 16.43
- EPS
- APLT N/A
- AMAL 3.39
- Revenue
- APLT N/A
- AMAL $303,032,000.00
- Revenue This Year
- APLT N/A
- AMAL N/A
- Revenue Next Year
- APLT $2,664.24
- AMAL $4.24
- P/E Ratio
- APLT N/A
- AMAL $9.87
- Revenue Growth
- APLT N/A
- AMAL 12.76
- 52 Week Low
- APLT $0.77
- AMAL $21.33
- 52 Week High
- APLT $10.62
- AMAL $38.19
- Technical
- Relative Strength Index (RSI)
- APLT 18.39
- AMAL 40.18
- Support Level
- APLT $0.78
- AMAL $33.05
- Resistance Level
- APLT $0.90
- AMAL $34.20
- Average True Range (ATR)
- APLT 0.11
- AMAL 0.90
- MACD
- APLT 0.25
- AMAL -0.13
- Stochastic Oscillator
- APLT 14.76
- AMAL 35.47
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About AMAL Amalgamated Financial Corp. (DE)
Amalgamated Financial Corp is a bank holding company. It is a full-service commercial bank and a chartered trust company. It provides commercial banking and trust services nationally and offers a range of products and services to commercial and retail customers. It offers a complete suite of commercial and retail banking, investment management, and trust and custody services.